First in Class Cat, Birch Allergen Blockers Succeed in Phase 3 Trials - HCPLive

Retrieved on: 2025-09-09 15:05:41

Tags for this article:

Click the tags to see associated articles and topics

First in Class Cat, Birch Allergen Blockers Succeed in Phase 3 Trials - HCPLive. View article details on hiswai:

Excerpt

The cat allergen trial evaluated a FelD1-blocking antibody combination therapy of REGN1908 and REGN1909, 2 fully human monoclonal antibodies (mAbs).

Article found on: www.hcplive.com